Westside Investment Management’s enVVeno Medical NVNO Stock Holding History

Westside Investment Management’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3K	Sell	1,525 -64	-4%	-$690	﹤0.01%	990
2026 Q1	$16.1K	Sell	1,589 -1,058	-40%	-$11.6K	﹤0.01%	972
2025 Q4	$29.7K	Sell	2,647 -3,433	-56%	-$66.7K	﹤0.01%	726
2025 Q3	$193K	Sell	6,080 -1,906	-24%	-$195K	0.03%	297
2025 Q2	$1.12M	Buy	7,986 +585	+8%	+$69.2K	0.21%	109
2025 Q1	$681K	Buy	7,401 +1,543	+26%	+$172K	0.15%	134
2024 Q4	$619K	Buy	5,858 +3,333	+132%	+$372K	0.13%	137
2024 Q3	$297K	Buy	2,525 +1,418	+128%	+$261K	0.06%	192
2024 Q2	$204K	Buy	1,107 +1,000	+935%	+$175K	0.05%	224
2024 Q1	$20.4K	Buy	+107	New	+$19.2K	﹤0.01%	515

Other funds holding NVNO

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

Westside Investment Management's NVNO Position: Q2 2026 in Review

Westside Investment Management reduced its enVVeno Medical (NVNO) stake by 4% in Q2 2026, selling an estimated $690 and leaving 1,525 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Westside Investment Management first reported a position in NVNO in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.12M in Q2 2025. 3 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

Westside Investment Management held 1,525 shares of enVVeno Medical worth $16.3K as of Q2 2026.
Westside Investment Management sold 64 enVVeno Medical shares in Q2 2026, an estimated $690.
enVVeno Medical made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #990 holding.
Westside Investment Management first reported a position in enVVeno Medical in Q1 2024 and has held it in 10 quarters since.
Westside Investment Management's enVVeno Medical position peaked at $1.12M in Q2 2025.
3 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.